Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, November 18, 2020
Thermo Fisher Scientific and the BATL at Northeastern University have entered into a collaborative agreement in a bid to advance analytical capabilities and drive innovation across the biopharmaceutical industry.
read more
Tuesday, November 10, 2020
Thermo Fisher Scientific and Innoforce have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China.
read more
Friday, September 18, 2020
Thermo Fisher Scientific announced collaborations of the PMSC with AstraZeneca and the University of Nebraska Medical Center as part of development of solutions for biomarker discovery
read more
The company is now supporting more than 200 of these projects globally.
read more
Wednesday, December 20, 2023
Thermo Fisher Scientific Inc. has introduced CorEvidence, a proprietary cloud-based data lake platform aimed at optimizing pharmacovigilance case processing and safety data management procedures. This innovative platform complements Thermo Fisher's ...
read more
Friday, November 08, 2019
Thermo Fisher Scientific is investing nearly $24 million in its Inchinnan, Scotland, site.
read more
Thermo Fisher Scientific is investing $150 million in its Pharma Services business to provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing.
read more
Thermo Fisher Scientific Inc. announced it will invest $97 million to expand its clinical research operations in Richmond, Virginia. The facilities, which include laboratory operations acquired with the purchase of PPD, Inc. in December 2021, will ...
read more
Thermo Fisher Scientific Inc. announced that it has entered into a definitive agreement to acquire The Binding Site Group (“The Binding Site”), a provider of specialty diagnostics, from a shareholder group led by European private equity firm Nordic ...
read more
Further expands service offering to pharma and biotech customers.
read more
Thermo Fisher Scientific and Patheon announced their boards of directors have approved Thermo Fisher's acquisition of Patheon.
read more
Friday, September 07, 2018
Thermo Fisher Scientific has signed a definitive agreement with BD under which Thermo Fisher will acquire BD's Advanced Bioprocessing business.
read more
Thermo Fisher Scientific and QIAGEN announced their boards of directors, as well as the managing board of QIAGEN, have unanimously approved Thermo Fisher's proposal to acquire QIAGEN for €39 per share in cash.
read more
Thermo Fisher Scientific has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline.
read more
Thermo Fisher Scientific and Brammer Bio announced they have entered into a definitive agreement under which Thermo Fisher will acquire Brammer Bio for approximately $1.7 billion in cash.
read more